15623698

Source:http://linkedlifedata.com/resource/pubmed/id/15623698

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002395, umls-concept:C0205081, umls-concept:C0547040, umls-concept:C0560005, umls-concept:C0814225, umls-concept:C1948041
pubmed:issue	12
pubmed:dateCreated	2004-12-29
pubmed:abstractText	To evaluate the efficacy of a cognitive-motor program in patients with early Alzheimer disease (AD) who are treated with a cholinesterase inhibitor (ChEI).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15623698-16043822
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Indans, http://linkedlifedata.com/resource/pubmed/chemical/Phenylcarbamates, http://linkedlifedata.com/resource/pubmed/chemical/Piperidines, http://linkedlifedata.com/resource/pubmed/chemical/donepezil, http://linkedlifedata.com/resource/pubmed/chemical/rivastigmine
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1526-632X
pubmed:author	pubmed-author:Cruz-JentoftA JAJ, pubmed-author:Fernández-BullidoYY, pubmed-author:FrankAA, pubmed-author:GalianoMM, pubmed-author:García de la RochaM LML, pubmed-author:González-SalvadorM TMT, pubmed-author:MuñizRR, pubmed-author:NavarroEE, pubmed-author:OlazaránJJ, pubmed-author:Peña-CasanovaJJ, pubmed-author:ReisbergBB, pubmed-author:SerraJ AJA, pubmed-author:SerranoPP, pubmed-author:SevillaCC, pubmed-author:del SerTT
pubmed:issnType	Electronic
pubmed:day	28
pubmed:volume	63
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2348-53
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15623698-Aged, pubmed-meshheading:15623698-Aged, 80 and over, pubmed-meshheading:15623698-Alzheimer Disease, pubmed-meshheading:15623698-Caregivers, pubmed-meshheading:15623698-Cholinesterase Inhibitors, pubmed-meshheading:15623698-Cognition Disorders, pubmed-meshheading:15623698-Cognitive Therapy, pubmed-meshheading:15623698-Combined Modality Therapy, pubmed-meshheading:15623698-Female, pubmed-meshheading:15623698-Follow-Up Studies, pubmed-meshheading:15623698-Humans, pubmed-meshheading:15623698-Indans, pubmed-meshheading:15623698-Male, pubmed-meshheading:15623698-Middle Aged, pubmed-meshheading:15623698-Patient Satisfaction, pubmed-meshheading:15623698-Patients, pubmed-meshheading:15623698-Phenylcarbamates, pubmed-meshheading:15623698-Physical Therapy Modalities, pubmed-meshheading:15623698-Piperidines, pubmed-meshheading:15623698-Psychomotor Disorders, pubmed-meshheading:15623698-Single-Blind Method, pubmed-meshheading:15623698-Treatment Outcome
pubmed:year	2004
pubmed:articleTitle	Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.
pubmed:affiliation	Fundación Maria Wolff, Madrid, Spain.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't